中文名:江苏合创宠物用品有限公司
- Pet Products
- Pet Cages & Houses
- Pet Toys & Daily Necessities
- Consumer Goods, Gifts & Leisure
- 8-Session Canton Fair Exhibitor
Jiangsu Hechuang Pet Products Co., Ltd. is a manufacturer of cat houses, dog crates, bird cages and other pet cages based in Funing County, Yancheng, Jiangsu, China. Established in May 2018 with a registered capital of CNY 10,000,000, the company operates a factory area of 10,000 to 29,999 m² and has participated in 8 sessions of the Canton Fair. It holds the titles of Quality Supplier and High-Tech Enterprise.
The company specializes in producing and selling a wide range of pet products, including iron, wooden and plastic pet enclosures, pet toys and daily necessities. Its main export markets are Japan, the United States and Australia. The company serves distributors, wholesalers and trading companies, offering reliable manufacturing capacity for pet cage and pet house product lines.
Key Highlights
- Manufacturer established in 2018 with registered capital of CNY 10,000,000.
- Factory area of 10,000 to 29,999 m² for pet cage production.
- 8 sessions of Canton Fair participation in the Pet Products section.
- Recognized as Quality Supplier and High-Tech Enterprise; exports to Japan, US, Australia.
FAQ
What products does Jiangsu Hechuang Pet Products Co., Ltd. manufacture?
Jiangsu Hechuang Pet Products Co., Ltd. manufactures cat houses, dog crates, bird cages and other pet cages, as well as pet toys and daily necessities. The company produces iron, wooden and plastic pet enclosures at its factory in Funing County, Yancheng, Jiangsu, China.
Which export markets does Jiangsu Hechuang Pet Products serve?
Jiangsu Hechuang Pet Products Co., Ltd. primarily exports to Japan, the United States and Australia. The company works with distributors, wholesalers and trading companies.
How many Canton Fair sessions has Jiangsu Hechuang Pet Products attended?
Jiangsu Hechuang Pet Products Co., Ltd. has participated in 8 sessions of the Canton Fair, exhibiting in the Pet Products section during Phase 3.